Skip to content

Experimental Biological/Vaccine,Placebo Comparator Biological/Vaccine

7 trials

Sponsors

None, Inovio Pharmaceuticals, Inc., Faculty of Medicine Ramathibodi Hospital, Research Administration Section, Faculty of Medicine, Thammasat university (Rangsit campus), Bavarian Nordic A/S

Conditions

Adult solid organ transplant recipients Monoclonal antibody kidney liver heart transplantCervical Dysplasia Cervical High Grade Squamous Intraepithelial Lesion HSILChikungunya disease Chikungunya virus virus-like particle, Chikungunya Disease, ImmunogenicityMelasma Melasma, chloasma, chloasma faciei, platelet rich fibrin, PRF, Autologous platelet concentration, APCPain and anxiety during endometrial sampling in women age at least 35 years old with abnormal uterine bleeding lavender aroma, pain, anxiety, endometrial sampling, abnormal uterine bleedingUrogenital atrophy vaginal atrophy urethral atrophy urinary incontinence pueraria mirificapediatric drug-resistant epilepsy patients Epilepsy, drug-resistance, lavender

Phase 2

Phase 3

REVEAL 1 (Randomized Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
Active, not recruitingTCTR20170301001
Inovio Pharmaceuticals, Inc.Cervical Dysplasia Cervical High Grade Squamous Intraepithelial Lesion HSIL
Start: 2017-06-28Updated: 2026-08-03
Efficacy of lavender aroma inhalation for pain and anxiety relief during endometrial sampling in women age at least 35 years old with abnormal uterine bleeding; randomized single-blind controlled trial
RecruitingTCTR20240522002
Research Administration Section, Faculty of Medicine, Thammasat university (Rangsit campus)Pain and anxiety during endometrial sampling in women age at least 35 years old with abnormal uterine bleeding lavender aroma, pain, anxiety, endometrial sampling, abnormal uterine bleeding
Start: 2024-05-12Target: 140Updated: 2026-08-03
A Phase 3b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of an Adjuvanted Chikungunya Virus Virus-like Particle (CHIKV VLP) Vaccine for the Prevention of Chikungunya Disease in Adolescents (12 to 18 Years) and Adults (18 Years or more than)
Active, not recruitingTCTR20240812007
Bavarian Nordic A/SChikungunya disease Chikungunya virus virus-like particle, Chikungunya Disease, Immunogenicity
Start: 2026-06-04Target: 6144Updated: 2026-08-03
Lavender aromatherapy as an adjunctive therapy for pediatric drug-resistant epilepsy patients: a randomized-placebo controlled trial
RecruitingTCTR20250130002
Phramongkutklao hospitalpediatric drug-resistant epilepsy patients Epilepsy, drug-resistance, lavender
Start: 2025-02-03Target: 120Updated: 2026-08-03
The Efficacy of Intralesional Platelet-rich Fibrin Injection Compared to Intralesional Normal Saline Injection of Melasma: A Randomized, Split-face, Prospective Control Trial
Active, not recruitingTCTR20260310005
Melasma Melasma, chloasma, chloasma faciei, platelet rich fibrin, PRF, Autologous platelet concentration, APC
Start: 2026-04-20Target: 15Updated: 2026-08-03

Phase 4

Related Papers